Cryolife Company Profile (NYSE:CRY)

About Cryolife

Cryolife logoCryoLife, Inc. (CryoLife) is engaged in medical device manufacturing and distribution, and in the processing and distribution of implantable human tissues for cardiac and vascular surgeries. The Company operates in two segments: Medical Devices and Preservation Services. The Medical Devices segment sells BioGlue, BioFoam, PerClot, CardioGenesis cardiac laser therapy, Hemodialysis Reliable Outflow (HeRO) Graft, and ProCol Vascular Bioprosthesis (ProCol). The Preservation Services segment preserves cardiac and vascular tissues. The Company's surgical sealants and hemostats include BioGlue Surgical Adhesive (BioGlue), BioFoam Surgical Matrix (BioFoam), and PerClot, an absorbable powdered hemostat, which the Company distributes internationally for Starch Medical, Inc. (SMI). Its CardioGenesis cardiac laser therapy product line includes a laser console system and single-use, fiber-optic handpieces.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Exchange: NYSE
  • Symbol: CRY
  • CUSIP: 22890310
Key Metrics:
  • Previous Close: $16.10
  • 50 Day Moving Average: $18.91
  • 200 Day Moving Average: $17.62
  • 52-Week Range: $32,848,000.00 - $9.10
  • Trailing P/E Ratio: 53.91
  • Foreward P/E Ratio: 33.17
  • P/E Growth: 1.37
  • Market Cap: $555.83M
  • Outstanding Shares: 32,848,000
  • Beta: 1.23
  • Net Margins: 6.00%
  • Return on Equity: 8.37%
  • Return on Assets: 5.77%
  • Debt-to-Equity Ratio: 0.34%
  • Current Ratio: 5.74%
  • Quick Ratio: 4.71%
Additional Links:
Companies Related to Cryolife:

Analyst Ratings

Consensus Ratings for Cryolife (NYSE:CRY) (?)
Ratings Breakdown: 5 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $19.60 (13.62% upside)

Analysts' Ratings History for Cryolife (NYSE:CRY)
DateFirmActionRatingPrice TargetDetails
2/17/2017Ladenburg Thalmann Financial ServicesUpgradeNeutral -> Buy$20.00View Rating Details
1/23/2017Canaccord GenuityReiterated RatingBuy$23.50View Rating Details
1/9/2017Northland SecuritiesInitiated CoverageOutperform$23.50View Rating Details
7/27/2016Piper Jaffray CompaniesReiterated RatingOverweight$16.00View Rating Details
6/15/2016Lake Street CapitalInitiated CoverageBuy$15.00View Rating Details
5/18/2015First AnalysisInitiated CoverageOverweight$14.00View Rating Details
(Data available from 2/19/2015 forward)


Earnings History for Cryolife (NYSE:CRY)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/15/2017Q416$0.09$0.12$46.92 million$45.00 millionViewListenView Earnings Details
10/26/2016Q316$0.05$0.13$44.90 million$45.30 millionViewListenView Earnings Details
7/25/2016Q216$0.02$0.13$35.50 million$47.10 millionViewListenView Earnings Details
4/27/2016Q116$0.02$0.10$40.50 million$43.00 millionViewListenView Earnings Details
2/16/2016Q415$0.05$0.13$40.04 million$39.80 millionViewListenView Earnings Details
10/27/2015Q315$0.01$0.10$38.17 million$36.70 millionViewListenView Earnings Details
7/28/2015Q215$0.03$35.57 million$35.50 millionViewListenView Earnings Details
4/28/2015Q115$0.01($0.01)$36.55 million$33.80 millionViewListenView Earnings Details
2/17/2015Q414$0.05$0.04$37.42 million$37.20 millionViewListenView Earnings Details
10/28/2014Q314$0.05$0.08$37.70 million$37.10 millionViewListenView Earnings Details
7/24/2014Q214$0.05$0.08$35.72 million$34.69 millionViewListenView Earnings Details
4/29/2014Q114$0.07$0.04$37.30 million$35.73 millionViewListenView Earnings Details
2/20/2014Q413$0.35$0.31$34.90 million$35.50 millionViewListenView Earnings Details
10/29/2013Q313$0.05$0.12$35.51 million$36.30 millionViewListenView Earnings Details
7/25/2013Q2 2013$0.07$0.08$35.63 million$33.50 millionViewListenView Earnings Details
4/30/2013Q1 2013$0.07$0.08$35.04 million$35.50 millionViewListenView Earnings Details
2/14/2013Q4 2012$0.05$0.08$33.58 million$32.80 millionViewListenView Earnings Details
10/30/2012Q312$0.04$0.08$32.45 million$33.40 millionViewN/AView Earnings Details
7/31/2012$0.05$0.10ViewN/AView Earnings Details
4/26/2012$0.05$0.04ViewN/AView Earnings Details
2/16/2012$0.06$0.07ViewN/AView Earnings Details
10/27/2011$0.08$0.07ViewN/AView Earnings Details
7/28/2011$0.06$0.12ViewN/AView Earnings Details
4/28/2011$0.08$0.09ViewN/AView Earnings Details
2/17/2011$0.07$0.08ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Cryolife (NYSE:CRY)
Current Year EPS Consensus Estimate: $0.44 EPS
Next Year EPS Consensus Estimate: $0.52 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161$0.01$0.01$0.01
Q2 20162$0.01$0.02$0.02
Q3 20162$0.01$0.04$0.03
Q4 20162$0.07$0.08$0.08
Q1 20172$0.06$0.07$0.07
Q2 20172$0.07$0.12$0.10
Q3 20172$0.07$0.13$0.10
Q4 20171$0.09$0.09$0.09
(Data provided by Zacks Investment Research)


Current Dividend Information for Cryolife (NYSE:CRY)
Annual Dividend:$0.00
Dividend Yield:0.00%
Dividend Growth:0.00% (3 Year Average)
Payout Ratio:0.00% (Based on Trailing 12 Months of Earnings)
0.00% (Based on Current Year Consensus EPS Estimate)
0.00% (Based on Next Year Consensus EPS Estimate)
Track Record:4 Years of Consecutive Dividend Growth

Dividend History for Cryolife (NYSE:CRY)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Cryolife (NYSE:CRY)
Insider Ownership Percentage: 6.08%
Institutional Ownership Percentage: 66.30%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/26/2016C Elkins RonaldDirectorSell2,000$14.00$28,000.00View SEC Filing  
6/1/2016Ronald D MccallDirectorSell10,000$11.56$115,600.00View SEC Filing  
5/10/2016James BensonDirectorSell5,000$12.22$61,100.00View SEC Filing  
4/15/2016C Elkins RonaldDirectorSell1,000$12.00$12,000.00View SEC Filing  
3/7/2016C Elkins RonaldDirectorSell2,000$11.18$22,360.00View SEC Filing  
3/4/2016James P MackinCEOBuy10,000$10.91$109,100.00View SEC Filing  
2/19/2016Scott B CappsVPSell15,000$10.30$154,500.00View SEC Filing  
2/18/2016David Ashley LeeCFOSell8,000$10.13$81,040.00View SEC Filing  
12/28/2015David Ashley LeeCFOSell700$11.00$7,700.00View SEC Filing  
11/30/2015David Ashley LeeCFOSell11,800$11.03$130,154.00View SEC Filing  
9/15/2015James BensonDirectorSell5,839$9.65$56,346.35View SEC Filing  
9/11/2015James BensonDirectorSell3,359$9.65$32,414.35View SEC Filing  
2/19/2015Steven G AndersonChairmanSell30,000$10.93$327,900.00View SEC Filing  
12/9/2014Bruce G AndersonVPSell3,900$10.29$40,131.00View SEC Filing  
11/25/2014Bruce G AndersonVPSell20,211$10.11$204,333.21View SEC Filing  
11/5/2014C Elkins RonaldDirectorSell4,000$10.08$40,320.00View SEC Filing  
11/3/2014James BensonDirectorSell10,000$10.22$102,200.00View SEC Filing  
9/8/2014Bruce G AndersonVPSell10,000$10.05$100,500.00View SEC Filing  
9/2/2014Steven G AndersonChairmanSell20,000$10.08$201,600.00View SEC Filing  
8/25/2014Bruce G AndersonVPSell5,000$10.05$50,250.00View SEC Filing  
8/18/2014Bruce G AndersonVPSell10,000$10.52$105,200.00View SEC Filing  
8/14/2014David Ashley LeeCFOSell10,000$10.51$105,100.00View SEC Filing  
8/13/2014David Ashley LeeCFOSell9,881$10.51$103,849.31View SEC Filing  
8/13/2014Jeffrey W BurrisVPSell11,000$10.50$115,500.00View SEC Filing  
7/29/2014C Elkins RonaldDirectorSell2,500$9.67$24,175.00View SEC Filing  
7/28/2014Bruce G AndersonVPSell5,000$9.48$47,400.00View SEC Filing  
7/28/2014Steven G AndersonCEOSell19,477$9.52$185,421.04View SEC Filing  
6/9/2014Amy HortonCAOSell2,500$9.26$23,150.00View SEC Filing  
5/16/2014David FronkVPSell8,952$8.61$77,076.72View SEC Filing  
5/13/2014Steven AndersonCEOSell30,523$9.00$274,707.00View SEC Filing  
5/6/2014Bruce AndersonVPSell16,870$8.83$148,962.10View SEC Filing  
11/26/2013Jeffrey BurrisVPSell5,000$10.50$52,500.00View SEC Filing  
11/11/2013Jeffrey BurrisVPSell5,000$10.00$50,000.00View SEC Filing  
11/7/2013Steven AndersonCEOSell100,000$9.38$938,000.00View SEC Filing  
10/29/2013C Elkins RonaldDirectorSell2,000$9.00$18,000.00View SEC Filing  
10/29/2013Jeffrey W BurrisVPSell5,000$9.00$45,000.00View SEC Filing  
8/27/2013Bruce AndersonVPSell4,500$6.33$28,485.00View SEC Filing  
8/8/2013Amy HortonCAOSell2,500$7.07$17,675.00View SEC Filing  
8/1/2013Ronald D MccallDirectorSell6,000$7.10$42,600.00View SEC Filing  
6/6/2013Ronald D MccallDirectorSell4,000$6.15$24,600.00View SEC Filing  
5/31/2013C Elkins RonaldDirectorSell2,250$6.15$13,837.50View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Cryolife (NYSE:CRY)
DateHeadline logoAnalyst Upgrades – CryoLife (NYSE:CRY) Stock Gets Upgraded By Ladenburg Thalmann Financial Services from Neutral to Buy (NYSE:CRY) - February 18 at 10:53 AM logoCryolife 4Q Revenues Missed Street Estimates (CRY) (NYSE:CRY) - February 17 at 5:35 PM logoCryoLife upgraded by Ladenburg Thalmann (NYSE:CRY) - February 17 at 5:35 PM logoCryolife 4Q Revenues Missed Street Estimates (NYSE:CRY) - February 17 at 5:35 PM logoEdited Transcript of CRY earnings conference call or presentation 16-Feb-17 1:00pm GMT (NYSE:CRY) - February 16 at 9:43 PM logoEdited Transcript of CRY earnings conference call or presentation 16-Feb-17 1:00pm GMT (NYSE:CRY) - February 16 at 9:43 PM
News IconInvestor Focus on Shares of CryoLife, Inc. (NYSE:CRY) - Benton Bulletin (NYSE:CRY) - February 16 at 4:37 PM
News IconMarket View: Technicals in Focus for CryoLife Inc. (CRY) - SKV News (NYSE:CRY) - February 16 at 4:37 PM
News IconFanning the Flames: Increased Volatility Noted on Shares of CryoLife, Inc. (NYSE:CRY) - Aiken Advocate (NYSE:CRY) - February 16 at 4:37 PM
News IconStock Dropping in Early Trade: CryoLife, Inc. (NYSE:CRY) - Aiken Advocate (NYSE:CRY) - February 16 at 4:37 PM logoCRYOLIFE INC : Results of Operations and Financial Condition (form 8-K) (NYSE:CRY) - February 16 at 12:29 PM
News IconCryoLife Inc (CRY): How fast will it grow? (NYSE:CRY) - February 16 at 12:29 PM logoBRIEF-CryoLife reports Q4 adj. earnings per share $0.12 (NYSE:CRY) - February 16 at 12:29 PM logoQ4 2016 CryoLife Inc Earnings Release - After Market Close (NYSE:CRY) - February 16 at 12:29 PM logoCryoLife Reports Fourth Quarter and Full Year 2016 Financial Results (NYSE:CRY) - February 16 at 12:29 PM logo5:28 pm CryoLife beats by $0.01, misses on revs; guides FY17 EPS in-line, revs in-line (NYSE:CRY) - February 16 at 12:29 PM logoCryoLife beats 4Q profit forecasts (NYSE:CRY) - February 16 at 12:28 PM logoCRYOLIFE INC Files SEC form 8-K, Results of Operations and Financial Condition (NYSE:CRY) - February 16 at 12:28 PM logoCryoLife Inc Earnings Call scheduled for 8:00 am ET today (NYSE:CRY) - February 16 at 12:28 PM logoCryoLife (CRY) Earnings Beat Estimates, Revenues Lag in Q4 (NYSE:CRY) - February 16 at 12:28 PM logoCryoLife Inc Earnings Call (Q4 2016) (NYSE:CRY) - February 14 at 10:28 PM
News IconGlobal Structural Heart Devices Market Expected to Reach $12,076 Million by 2022 - Allied Market Research (NYSE:CRY) - February 13 at 5:11 PM
News IconGlobal Surgical Sealants and Adhesives Market 2017 – Johnson & Johnson, CryoLife, Inc (NYSE:CRY) - February 11 at 2:56 AM logoCryoLife, Inc. (NYSE:CRY) Accounts Payable Is $5.688 For The Quarter Ended 2016-09-30 - (NYSE:CRY) - February 10 at 9:54 PM logoGlobal Bioadhesives Market: Efforts towards Promoting Use of Environmental-friendly Bioadhesives across Industries to Boost Growth, says TMR (NYSE:CRY) - February 10 at 3:02 AM
News IconGlobal Hemostats Market 2016: By Manufacturers, Regions, Type and Application (NYSE:CRY) - February 9 at 9:59 PM logoAdirondack Research & Management Inc. Buys G-III Apparel Group, Jakks Pacific, Cowen Group, Sells Cryolife ... - (NYSE:CRY) - February 8 at 4:55 PM
News IconFibrin Glue Market: Thrust on Product Innovation Drives Growth (NYSE:CRY) - February 7 at 10:40 PM logoBiosurgery: Technologies and Global Markets (NYSE:CRY) - February 7 at 10:40 PM logoFibrin Glue Market Expected to Show Steady Growth by 2021 (NYSE:CRY) - February 7 at 5:38 PM logoProsthetic Heart Valve Market Projected to Register a CAGR of 12.0% Between 2016 and 2026 (NYSE:CRY) - February 7 at 5:38 PM logoCryoLife Announces Release Date and Teleconference Call Details for 2016 Fourth Quarter and Year-End Financial Results (NYSE:CRY) - February 7 at 5:38 PM logoTissue Engineering Market Will Expected to Exceed USD 94.7 Billion by 2024 | Hexa Research (NYSE:CRY) - February 6 at 5:40 AM logoETFs with exposure to CryoLife, Inc. : February 3, 2017 (NYSE:CRY) - February 3 at 4:49 PM logoTissue Transplantation Products and Services Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016-2024 (NYSE:CRY) - February 2 at 4:54 PM logoCryoLife, Inc. breached its 50 day moving average in a Bullish Manner : CRY-US : February 2, 2017 (NYSE:CRY) - February 2 at 4:54 PM logoGlobal Bioadhesives Market to Register a Robust Growth By 2021 (NYSE:CRY) - February 1 at 4:53 PM logoFibrin Glue Market Revenue, Opportunity, Forecast and Value Chain 2014-2020 (NYSE:CRY) - January 31 at 5:04 PM
News IconGlobal Biosurgery Equipment Market by Product & Data Validation, Analysis and Forecast 2022 (NYSE:CRY) - January 31 at 5:04 PM
News IconWhat’s Next for Cryolife Inc (CRY) After Forming Double Top Chart Pattern? (NYSE:CRY) - January 30 at 10:27 PM
News IconProsthetic Heart Valve Market Analysis Will Expand at a CAGR of 12.0% from 2016 to 2026 (NYSE:CRY) - January 30 at 5:26 PM
News IconLooking Ahead for CryoLife, Inc. (NYSE:CRY); Are These Shares Ready to Go Higher? - Aiken Advocate (NYSE:CRY) - January 30 at 8:35 AM logoCryoLife, Inc. (NYSE:CRY) Deferred Tax Assets At $5.729 Millions - (NYSE:CRY) - January 27 at 5:58 PM
News IconTissue Engineering Market to grow at an Exponential Rate Till 2024 | Hexa Research (NYSE:CRY) - January 27 at 3:43 AM
News IconGlobal Tissue Engineering Market Industry Trends & Forecasts to 2022 (NYSE:CRY) - January 26 at 3:42 AM
News IconBiosurgery Global Market, By Product & Data Validation, 2016 Analysis and Forecast 2022 (NYSE:CRY) - January 25 at 5:38 PM logoGlobal Bioadhesives Market to Register a Strong Growth By 2021 (NYSE:CRY) - January 24 at 10:08 PM
News IconNew study: The surgical sealants and adhesives market has experienced stable growth (NYSE:CRY) - January 24 at 10:08 PM
News IconSell-side is Weighing in on CryoLife, Inc. (NYSE:CRY) Earnings - Aiken Advocate (NYSE:CRY) - January 24 at 2:52 AM logoQuarterly Deferred Tax Assets Of CryoLife, Inc. (NYSE:CRY) At $5.729 Millions - (NYSE:CRY) - January 21 at 9:34 PM


What is Cryolife's stock symbol?

Cryolife trades on the New York Stock Exchange (NYSE) under the ticker symbol "CRY."

Where is Cryolife's stock going? Where will Cryolife's stock price be in 2017?

5 equities research analysts have issued 12-month price objectives for Cryolife's shares. Their forecasts range from $15.00 to $23.50. On average, they anticipate Cryolife's stock price to reach $19.60 in the next year.

When will Cryolife announce their earnings?

Cryolife is scheduled to release their next quarterly earnings announcement on Tuesday, April, 25th 2017.

Who owns Cryolife stock?

Cryolife's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Dimensional Fund Advisors LP (5.32%), State Street Corp (2.12%), Renaissance Technologies LLC (1.60%), Castleark Management LLC (1.59%), FMR LLC (1.46%) and Royce & Associates LP (0.91%). Company insiders that own Cryolife stock include C Elkins Ronald, David Ashley Lee, James Benson, James P Mackin, Ronald D Mccall, Scott B Capps and Steven G Anderson.

Who sold Cryolife stock? Who is selling Cryolife stock?

Cryolife's stock was sold by a variety of institutional investors in the last quarter, including Perritt Capital Management Inc., Two Sigma Investments LP, Renaissance Technologies LLC, Royce & Associates LP, Menta Capital LLC, Castleark Management LLC and State Board of Administration of Florida Retirement System. Company insiders that have sold Cryolife stock in the last year include C Elkins Ronald, James Benson, Ronald D Mccall and Scott B Capps.

Who bought Cryolife stock? Who is buying Cryolife stock?

Cryolife's stock was acquired by a variety of institutional investors in the last quarter, including Dimensional Fund Advisors LP, Axiom International Investors LLC DE, State Street Corp, Allianz Asset Management AG, FMR LLC, Guggenheim Capital LLC, Russell Investments Group Ltd. and Friess Associates LLC.

How do I buy Cryolife stock?

Shares of Cryolife can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Cryolife stock cost?

One share of Cryolife stock can currently be purchased for approximately $17.25.

Cryolife (NYSE:CRY) Chart for Sunday, February, 19, 2017

Institutional Ownership Chart

Institutional Ownership by Quarter for Cryolife (NYSE:CRY)

Earnings History Chart

Earnings by Quarter for Cryolife (NYSE:CRY)

Dividend History Chart

Dividend Payments by Quarter for Cryolife (NYSE:CRY)

Last Updated on 2/19/2017 by Staff